Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00343109
What this trial is testing

Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerStage IIIB Breast Cancer+2 more
University of Washington 38
Large-scale testing (Phase 3)Study completedNCT00146549
What this trial is testing

Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer

Who this might be right for
Breast CancerStage IV Breast Cancer
Dana-Farber Cancer Institute 250
Testing effectiveness (Phase 2)Study completedNCT01042925
What this trial is testing

Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen

Who this might be right for
Breast CancerBreast Neoplasms
Sanofi 42
Testing effectiveness (Phase 2)Study completedNCT01622868
What this trial is testing

Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer

Who this might be right for
HER2-Positive Breast CarcinomaInvasive Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+2 more
National Cancer Institute (NCI) 143
Not applicableEnrolling By InvitationNCT06821490
What this trial is testing

Validation of TAD in HER-2 with More Than 2 Lymph Nodes

Who this might be right for
Breast Carcinoma Metastatic in Lymph NodeHER2 Positive Breast Carcinoma
Fundación para la Investigación del Hospital Clínico de Valencia 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT07366840
What this trial is testing

RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure

Who this might be right for
HER2-positive Breast CancerMetastatic Breast Cancer
Fudan University 268
Testing effectiveness (Phase 2)Active Not RecruitingNCT03587740
What this trial is testing

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 111
Not applicableNot Yet RecruitingNCT06015113
What this trial is testing

Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis

Who this might be right for
Breast Cancer
Xi'an International Medical Center Hospital 20
Not applicableEnded earlyNCT01712815
What this trial is testing

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer

Who this might be right for
HER2-positive Breast CancerRecurrent Breast CancerStage IA Breast Cancer+6 more
University of Southern California 12
Early research (Phase 1)Study completedNCT01009437
What this trial is testing

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 28
Large-scale testing (Phase 3)Study completedNCT02492711
What this trial is testing

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

Who this might be right for
HER-2 Positive Breast CancerMetastatic Neoplasm
MacroGenics 624
Early research (Phase 1)Looking for participantsNCT06251544
What this trial is testing

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

Who this might be right for
Breast CancerTumor, BreastBreast Tumor+5 more
Baylor College of Medicine 27
Large-scale testing (Phase 3)Study completedNCT02125344
What this trial is testing

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Who this might be right for
Tubular Breast Cancer Stage IITubular Breast Cancer Stage IIIMucinous Breast Cancer Stage II+4 more
GBG Forschungs GmbH 961
Not applicableLooking for participantsNCT07166185
What this trial is testing

Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast Cancer

Who this might be right for
Non Metastatic HER2 Positive Breast Cancer
Blida 1 University 70
Testing effectiveness (Phase 2)UnknownNCT00431704
What this trial is testing

VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
National Cancer Institute, Naples 39
Not applicableStudy completedNCT03714243
What this trial is testing

Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
InSightec 8
Not applicableActive Not RecruitingNCT05959291
What this trial is testing

Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerStage IV Breast Cancer
University of Miami 20
Testing effectiveness (Phase 2)UnknownNCT05619016
What this trial is testing

[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors

Who this might be right for
Esophageal NeoplasmsGastric Neoplasms MalignantBreast Cancer+1 more
Karolinska University Hospital 72
Testing effectiveness (Phase 2)Study completedNCT00470704
What this trial is testing

Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Nancy Lin, MD 87
Testing effectiveness (Phase 2)UnknownNCT05945368
What this trial is testing

A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC

Who this might be right for
HER2-positive Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 78
Next Page